284 results on '"Uehara, Takeki"'
Search Results
2. Baloxavir safety and clinical and virologic outcomes in influenza virus-infected pediatric patients by age group: age-based pooled analysis of two pediatric studies conducted in Japan
3. How to Use Anti-influenza Drugs: Baloxavir Marboxil
4. Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID‐19: An Exploratory Analysis of a Multicenter, Randomized, Phase 2b/3 Clinical Trial.
5. Open-label study of the safety, pharmacokinetics, and effectiveness of a 2 mg/kg dose of baloxavir marboxil 2% granules in children
6. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial
7. How to Use Anti-influenza Drugs: Baloxavir Marboxil
8. Novel miRNA biomarkers for genotoxicity screening in mouse
9. A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part)
10. Baloxavir Marboxil 2% Granules in Japanese Children With Influenza: An Open-label Phase 3 Study
11. Toxicogenomic and Pharmacogenomic Biomarkers for Drug Discovery and Personalized Medicine
12. Investigating the transmission of baloxavir‐resistant influenza viruses from treated index patients to untreated household contacts in the BLOCKSTONE study
13. Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study
14. 1133. Investigation of Treatment-Emergent Amino Acid Substitutions in Nonstructural Protein 5 from Ph2a Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor
15. Additional file 2 of Baloxavir safety and clinical and virologic outcomes in influenza virus-infected pediatric patients by age group: age-based pooled analysis of two pediatric studies conducted in Japan
16. Additional file 5 of Baloxavir safety and clinical and virologic outcomes in influenza virus-infected pediatric patients by age group: age-based pooled analysis of two pediatric studies conducted in Japan
17. Additional file 4 of Baloxavir safety and clinical and virologic outcomes in influenza virus-infected pediatric patients by age group: age-based pooled analysis of two pediatric studies conducted in Japan
18. Additional file 6 of Baloxavir safety and clinical and virologic outcomes in influenza virus-infected pediatric patients by age group: age-based pooled analysis of two pediatric studies conducted in Japan
19. Additional file 1 of Baloxavir safety and clinical and virologic outcomes in influenza virus-infected pediatric patients by age group: age-based pooled analysis of two pediatric studies conducted in Japan
20. Additional file 3 of Baloxavir safety and clinical and virologic outcomes in influenza virus-infected pediatric patients by age group: age-based pooled analysis of two pediatric studies conducted in Japan
21. List of Contributors
22. Esophagus and Stomach
23. A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part
24. Comparative gene and protein expression analyses of a panel of cytokines in acute and chronic drug-induced liver injury in rats
25. A Phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part)
26. Efficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19: the phase 2b part of a randomized, placebo-controlled, phase 2/3 study
27. Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity
28. Effects of pirfenidone in acute and sub-chronic liver fibrosis, and an initiation-promotion cancer model in the mouse
29. Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study.
30. Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil
31. Toxicogenomic biomarkers for renal papillary injury in rats
32. Toxicogenomic multigene biomarker for predicting the future onset of proximal tubular injury in rats
33. Decrease in urinary creatinine in acute kidney injury influences diagnostic value of urinary biomarker-to-creatinine ratio in rats
34. A toxicogenomic approach for identifying biomarkers for myelosuppressive anemia in rats
35. The DEN and CCl4‐Induced Mouse Model of Fibrosis and Inflammation‐Associated Hepatocellular Carcinoma
36. Differentially Expressed MicroRNAs Provide Mechanistic Insight into Fibrosis-Associated Liver Carcinogenesis in Mice
37. Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats
38. Identification of potential genomic biomarkers for early detection of chemically induced cardiotoxicity in rats
39. Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model
40. Evaluation of the usefulness of biomarkers for cardiac and skeletal myotoxicity in rats
41. Identification of genomic biomarkers for concurrent diagnosis of drug-induced renal tubular injury using a large-scale toxicogenomics database
42. Toxicogenomic and Pharmacogenomic Biomarkers for Drug Discovery and Personalized Medicine
43. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice
44. Comment to: Baloxavir efficacy in North American Adults
45. Baloxavir Treatment in Adolescents With Acute Influenza: Subgroup Analysis From the CAPSTONE-1 Trial
46. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats
47. Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model
48. Molecular Mechanisms of Fibrosis-Associated Promotion of Liver Carcinogenesis
49. Acetaminophen-induced acute liver injury in HCV transgenic mice
50. Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19: The SCORPIO-SR Randomized Clinical Trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.